BusinessFoamix Announces Positive Results From Phase 1 Study to Characterize Minocycline Bioavailability of FMX-101 Compared to Solodyn® (Minocycline HCl) Extended-Release TabletsBy Nasdaq OMXJan 7, 2016, 9:01 PM UTC